Teleflex (TFX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $128.22, +4.00% vs the prior close of $123.29.
- Volume 907.00K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TFX jumps 4.0% to $128.22, a 1-month high. Closed at $128.22, +4.00% vs the prior close of $123.29. Day range $123.75–$128.59, opened at $124.00.
TFX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — TFX jumps 4.0% to $128.22, a 1-month high
- Closed at $128.22, +4.00% vs the prior close of $123.29. Day range $123.75–$128.59, opened at $124.00.
- Volume was 907.00K shares, 1.3x its 50-day average of 724.51K.
- Price is -2.3% vs its 50-day average ($131.27) and +3.3% vs its 200-day average ($124.11).
- 52-week range $100.18–$145.00; today's close sits at 63% of that range, 11.6% below the 52-week high.
Oct 14, 2026 — TFX dips 0.9% to $123.29
- Closed at $123.29, -0.92% vs the prior close of $124.44. Day range $123.11–$124.89, opened at $123.86.
- Volume was 706.50K shares, 1.0x its 50-day average of 722.48K.
- Price is -6.2% vs its 50-day average ($131.44) and -0.6% vs its 200-day average ($124.08).
- 52-week range $100.18–$145.00; today's close sits at 52% of that range, 15.0% below the 52-week high.
Oct 13, 2026 — TFX dips 1.0% to $124.44
- Closed at $124.44, -1.00% vs the prior close of $125.70. Day range $123.05–$126.56, opened at $125.64.
- Volume was 552.40K shares, 0.8x its 50-day average of 731.63K.
- Price is -5.6% vs its 50-day average ($131.78) and +0.3% vs its 200-day average ($124.08).
- 52-week range $100.18–$145.00; today's close sits at 54% of that range, 14.2% below the 52-week high.
Oct 12, 2026 — TFX rises 0.5% to $125.70
- Closed at $125.70, +0.46% vs the prior close of $125.12. Day range $123.74–$126.81, opened at $124.74.
- Volume was 621.40K shares, 0.9x its 50-day average of 730.36K.
- Price is -4.8% vs its 50-day average ($132.08) and +1.3% vs its 200-day average ($124.07).
- 52-week range $100.18–$145.00; today's close sits at 57% of that range, 13.3% below the 52-week high.
Oct 9, 2026 — TFX rises 0.7% to $125.12
- Closed at $125.12, +0.75% vs the prior close of $124.19. Day range $123.56–$126.01, opened at $124.84.
- Volume was 424.70K shares, 0.6x its 50-day average of 729.36K — lighter than usual.
- Price is -5.4% vs its 50-day average ($132.30) and +0.9% vs its 200-day average ($124.05).
- 52-week range $100.18–$145.00; today's close sits at 56% of that range, 13.7% below the 52-week high.
Oct 8, 2026 — TFX ends flat (-0.2%) to $124.19, 3 down days in a row
- Closed at $124.19, -0.23% vs the prior close of $124.48. Day range $122.06–$124.95, opened at $124.02.
- Volume was 1.00M shares, 1.4x its 50-day average of 720.30K.
- Price is -6.2% vs its 50-day average ($132.45) and +0.1% vs its 200-day average ($124.05).
- 52-week range $100.18–$145.00; today's close sits at 54% of that range, 14.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — TFX ends flat (-0.2%) to $124.48
- Closed at $124.48, -0.21% vs the prior close of $124.74. Day range $122.84–$126.84, opened at $125.07.
- Volume was 928.30K shares, 1.3x its 50-day average of 708.95K.
- Price is -6.2% vs its 50-day average ($132.66) and +0.4% vs its 200-day average ($124.04).
- 52-week range $100.18–$145.00; today's close sits at 54% of that range, 14.2% below the 52-week high.
Oct 6, 2026 — TFX dips 0.4% to $124.74
- Closed at $124.74, -0.40% vs the prior close of $125.24. Day range $123.81–$126.94, opened at $125.60.
- Volume was 683.30K shares, 1.0x its 50-day average of 703.93K.
- Price is -6.1% vs its 50-day average ($132.85) and +0.6% vs its 200-day average ($124.04).
- 52-week range $100.18–$145.00; today's close sits at 55% of that range, 14.0% below the 52-week high.
Oct 5, 2026 — TFX rises 0.9% to $125.24
- Closed at $125.24, +0.90% vs the prior close of $124.12. Day range $123.23–$127.44, opened at $124.52.
- Volume was 561.60K shares, 0.8x its 50-day average of 702.99K.
- Price is -5.8% vs its 50-day average ($132.98) and +1.0% vs its 200-day average ($124.04).
- 52-week range $100.18–$145.00; today's close sits at 56% of that range, 13.6% below the 52-week high.
Oct 2, 2026 — TFX dips 1.6% to $124.12
- Closed at $124.12, -1.58% vs the prior close of $126.11. Day range $124.01–$127.12, opened at $127.12.
- Volume was 647.00K shares, 0.9x its 50-day average of 698.42K.
- Price is -6.8% vs its 50-day average ($133.11) and +0.1% vs its 200-day average ($124.04).
- 52-week range $100.18–$145.00; today's close sits at 53% of that range, 14.4% below the 52-week high.
TFX latest news & SEC filings
Every SEC filing by or about TFX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 9, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 8, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $570.33M (prior year $442.52M) (+28.9% vs Jun 29, 2025)
- Net income: $99.69M (prior year $122.58M) (-18.7% vs Jun 29, 2025)
- Diluted EPS: $2.28 (prior year $2.77) (-17.7% vs Jun 29, 2025)
Aug 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 5, 2026 · 8-K/A — Amended current report
Amended current report
- Exhibits / financial statements only (Item 9.01).
Aug 3, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 26, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade TFX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.21% (largest 4.3%).
- Liquidity: about 845.54K shares (≈$108.42M) trade per day on average.
- 52-week position: $128.22 vs a range of $100.18–$145.00 (63% of the range).
- Dividends: last ex-dividend date Aug 14, 2026 ($0.34/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 9, 2026; 8-K Aug 7, 2026; 10-Q Aug 6, 2026.
- Share count: 42.37M shares outstanding (Aug 4, 2026), -4.1% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Surgical & Medical Instruments & Apparatus.
TFX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 124.00 | 128.59 | 123.75 | 128.22 | 907.00K |
| Oct 14, 2026 | 123.86 | 124.89 | 123.11 | 123.29 | 706.50K |
| Oct 13, 2026 | 125.64 | 126.56 | 123.05 | 124.44 | 552.40K |
| Oct 12, 2026 | 124.74 | 126.81 | 123.74 | 125.70 | 621.40K |
| Oct 9, 2026 | 124.84 | 126.01 | 123.56 | 125.12 | 424.70K |
| Oct 8, 2026 | 124.02 | 124.95 | 122.06 | 124.19 | 1.00M |
| Oct 7, 2026 | 125.07 | 126.84 | 122.84 | 124.48 | 928.30K |
| Oct 6, 2026 | 125.60 | 126.94 | 123.81 | 124.74 | 683.30K |
| Oct 5, 2026 | 124.52 | 127.44 | 123.23 | 125.24 | 561.60K |
| Oct 2, 2026 | 127.12 | 127.12 | 124.01 | 124.12 | 647.00K |
| Oct 1, 2026 | 125.06 | 126.53 | 124.25 | 126.11 | 719.20K |
| Sep 30, 2026 | 126.08 | 127.06 | 124.37 | 125.04 | 644.70K |
| Sep 29, 2026 | 127.07 | 127.70 | 124.01 | 126.32 | 982.60K |
| Sep 28, 2026 | 124.26 | 128.62 | 123.52 | 127.38 | 1.58M |
| Sep 25, 2026 | 120.47 | 123.05 | 118.31 | 122.07 | 857.30K |
| Sep 24, 2026 | 122.34 | 123.14 | 119.86 | 120.09 | 869.60K |
| Sep 23, 2026 | 124.71 | 125.16 | 121.12 | 121.75 | 832.60K |
| Sep 22, 2026 | 126.35 | 127.07 | 124.16 | 124.90 | 777.10K |
| Sep 21, 2026 | 124.84 | 126.23 | 123.10 | 124.80 | 815.20K |
| Sep 18, 2026 | 125.03 | 125.83 | 124.01 | 124.52 | 1.80M |
About Teleflex
Teleflex (TFX) is listed on the NYSE and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in WAYNE, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 96943.
TFX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Candace H Duncan | Director | May 19, 2026 |
| Gretchen R Haggerty | Director | May 19, 2026 |
| Andrew A Krakauer | Director | May 19, 2026 |
| Neena M Patil | Director | May 19, 2026 |
| Stuart A Randle | Director | Jun 9, 2026 |
| Jaewon Ryu | Director | May 19, 2026 |
| Sean Salmon | Director | Sep 10, 2026 |
| Michael J Tokich | Director | May 19, 2026 |
| Jason R. Weidman | President and CEO | Jun 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Deren | Executive Vice President & CFO | Mar 5, 2026 |
| Cameron P Hicks | Corp. VP & Chief HR Officer | Mar 5, 2026 |
| Daniel V. Logue | CVP, General Counsel & Secty | Mar 5, 2026 |
| Dominik Michal Reterski | Corporate Vice President, QARA | Apr 13, 2026 |
| Jason R. Weidman | President and CEO | Jun 9, 2026 |
| James Winters | Corp VP, Mfg and Supply | Mar 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
TFX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.99B | $-905.64M | -20.25 | — |
| Dec 31, 2024 | $1.70B | $69.67M | 1.48 | — |
| Dec 31, 2023 | $1.71B | $356.33M | 7.53 | — |
| Dec 31, 2022 | $2.79B | $363.14M | 7.68 | — |
| Dec 31, 2021 | $2.81B | $485.37M | 10.23 | — |
Latest balance sheet: total assets $6.79B, total liabilities $3.88B, cash $300.16M (as of Jun 30, 2026).
TFX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $138.89 |
| May 7, 2026 | 8-K Item 2.02 (results) | $131.68 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $119.02 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $110.01 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $108.51 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $119.50 |
| May 1, 2025 | 8-K Item 2.02 (results) | $125.87 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $139.11 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $201.06 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on TFX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.